ArticlePediatric blood & cancer2014

Initial testing (stage 1) of glembatumumab vedotin (CDX-011) by the pediatric preclinical testing program.

E Anders Kolb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.